ALCAR Stock Overview
Designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Carmat SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.46 |
| 52 Week High | €9.99 |
| 52 Week Low | €1.81 |
| Beta | 1.38 |
| 11 Month Change | -18.00% |
| 3 Month Change | -38.96% |
| 1 Year Change | -65.40% |
| 33 Year Change | -90.06% |
| 5 Year Change | -87.31% |
| Change since IPO | -88.87% |
Recent News & Updates
Shareholder Returns
| ALCAR | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 13.9% | 1.1% | 1.5% |
| 1Y | -65.4% | 21.3% | 3.1% |
Return vs Industry: ALCAR underperformed the French Medical Equipment industry which returned 21.3% over the past year.
Return vs Market: ALCAR underperformed the French Market which returned 3.1% over the past year.
Price Volatility
| ALCAR volatility | |
|---|---|
| ALCAR Average Weekly Movement | 13.1% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in FR Market | 9.4% |
| 10% least volatile stocks in FR Market | 2.6% |
Stable Share Price: ALCAR's share price has been volatile over the past 3 months.
Volatility Over Time: ALCAR's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 182 | Stephane Piat | www.carmatsa.com |
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA Fundamentals Summary
| ALCAR fundamental statistics | |
|---|---|
| Market cap | €84.75m |
| Earnings (TTM) | -€53.87m |
| Revenue (TTM) | €3.84m |
22.1x
P/S Ratio-1.6x
P/E RatioIs ALCAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALCAR income statement (TTM) | |
|---|---|
| Revenue | €3.84m |
| Cost of Revenue | €39.29m |
| Gross Profit | -€35.45m |
| Other Expenses | €18.42m |
| Earnings | -€53.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 11, 2024
| Earnings per share (EPS) | -1.56 |
| Gross Margin | -923.85% |
| Net Profit Margin | -1,403.94% |
| Debt/Equity Ratio | -214.0% |
How did ALCAR perform over the long term?
See historical performance and comparison